Daniel Tardiff

Daniel Tardiff

Company: Yumanity

Job title: Director, Discovery Biology

Seminars:

Discovery & Clinical Translation of a Small-Molecule Inhibitor of α-Synuclein Toxicity 3:50 pm

• Using a yeast-to-human phenotypic screening platform we recently discovered that small molecule inhibitors of stearoyl-coA-desaturase (SCD) potently protect cells from α-synuclein toxicity • Preclinical data confirmed that reduction of fatty-acid desaturation is correlated with protection, providing a translational pharmacodynamic marker that can be used in animals and human studies • Focusing on the preclinical…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.